VINRKLB
Rekvina Laboratories share price & financials
- Price
- ₹54.93
- Market cap
- ₹25 Cr
Quarterly results
Q1 FY27: net profit down 200.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| EBITDA | -0 | -0 | -0 | -0 | -0 +57% | -0 −500% | -0 −50% | -0 −200% |
| Net profit | -0 | -0 | -0 | -0 | -0 +57% | -0 −500% | -0 −50% | -0 −200% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +1120.7% 1Y
1Y: ₹4.5 on 13 Dec 2021 → ₹54.93. High ₹59.4 (11 Sept 2026), low ₹4.5 (13 Dec 2021).
Valuation and ratios
Current values use the same calculations as the financial screener. Compare FY and TTM where available. Each ratio shows its reporting period.
Source refresh pending. Available figures use the shared formulas; missing inputs remain blank.
- Return on capital employed
- —
- TTM · period unavailable
How it is calculated
Adjusted EBIT ÷ average capital employed, including minority equity and deposits.
- —
- FY · period unavailable
How it is calculated
Adjusted EBIT ÷ average capital employed, including minority equity and deposits.
- Return on equity
- —
- TTM · period unavailable
How it is calculated
Adjusted profit attributable to owners ÷ average owners’ equity.
- —
- FY · period unavailable
How it is calculated
Adjusted profit attributable to owners ÷ average owners’ equity.
- Return on assets
- —
- TTM · period unavailable
How it is calculated
Total profit excluding exceptional items after tax ÷ average total assets.
- —
- FY · period unavailable
How it is calculated
Total profit excluding exceptional items after tax ÷ average total assets.
- Operating margin (EBITDA)
- —
- TTM · period unavailable
How it is calculated
Operating profit ÷ revenue.
- —
- FY · period unavailable
How it is calculated
Operating profit ÷ revenue.
- Net margin
- —
- TTM · period unavailable
How it is calculated
Total profit excluding exceptional items after tax ÷ revenue.
- —
- FY · period unavailable
How it is calculated
Total profit excluding exceptional items after tax ÷ revenue.
- Free cash flow margin
- —
- FY · period unavailable
How it is calculated
(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
- Cash conversion (CFO/PAT)
- —
- FY · period unavailable
How it is calculated
Operating cash flow ÷ reported total net profit.
- Capex intensity
- —
- FY · period unavailable
How it is calculated
Fixed-asset purchases ÷ revenue.
- Revenue growth (YoY)
- —
- TTM · period unavailable
How it is calculated
Revenue change against the same period one year earlier.
- —
- FY · period unavailable
How it is calculated
Revenue change against the same period one year earlier.
- PAT growth (YoY)
- —
- TTM · period unavailable
How it is calculated
Adjusted profit attributable to owners vs the same period one year earlier.
- —
- FY · period unavailable
How it is calculated
Adjusted profit attributable to owners vs the same period one year earlier.
- EBITDA growth (YoY)
- —
- TTM · period unavailable
How it is calculated
Operating profit vs the same period one year earlier.
- —
- FY · period unavailable
How it is calculated
Operating profit vs the same period one year earlier.
- Debt to equity
- —
- FY · period unavailable
How it is calculated
Borrowings ÷ owners’ equity.
- Interest coverage
- —
- TTM · period unavailable
How it is calculated
Adjusted EBIT ÷ interest expense.
- —
- FY · period unavailable
How it is calculated
Adjusted EBIT ÷ interest expense.
- Asset turnover
- —
- TTM · period unavailable
How it is calculated
Revenue ÷ average total assets.
- —
- FY · period unavailable
How it is calculated
Revenue ÷ average total assets.
- Net debt
- —
- FY · period unavailable
How it is calculated
Borrowings less cash equivalents.
- Net debt / EBITDA
- —
- TTM · period unavailable
How it is calculated
(Borrowings − cash equivalents) ÷ adjusted EBITDA.
- —
- FY · period unavailable
How it is calculated
(Borrowings − cash equivalents) ÷ adjusted EBITDA.
- Financial leverage (average assets/equity)
- —
- FY · period unavailable
How it is calculated
Average total assets ÷ closing owners’ equity.
- Net interest income
- —
- TTM · period unavailable
How it is calculated
Interest earned less interest expense.
- —
- FY · period unavailable
How it is calculated
Interest earned less interest expense.
- Deposit growth
- —
- FY · period unavailable
How it is calculated
Deposits vs the same period one year earlier.
- Price to earnings
- —
- TTM · period unavailable
How it is calculated
Current market cap ÷ adjusted profit attributable to owners for the selected income period. Uses current market cap, not the share price at the period end.
- —
- FY · period unavailable
How it is calculated
Current market cap ÷ adjusted profit attributable to owners for the selected income period. Uses current market cap, not the share price at the period end.
- Price to book
- —
- TTM · period unavailable
How it is calculated
Market cap ÷ owners’ equity from the balance sheet selected for the TTM inputs. Uses current market cap, not the share price at the period end.
- EV / EBITDA
- —
- TTM · period unavailable
How it is calculated
(Market cap + borrowings + deposits − cash equivalents) ÷ adjusted EBITDA. Uses current market cap, not the share price at the period end.
- —
- FY · period unavailable
How it is calculated
(Market cap + borrowings + deposits − cash equivalents) ÷ adjusted EBITDA. Uses current market cap, not the share price at the period end.
- Earnings yield
- —
- TTM · period unavailable
How it is calculated
Adjusted EBIT ÷ enterprise value. Uses current market cap, not the share price at the period end.
- —
- FY · period unavailable
How it is calculated
Adjusted EBIT ÷ enterprise value. Uses current market cap, not the share price at the period end.
- Debtor days
- 172.44 days
- FY ending Mar 2026
How it is calculated
Reported receivable days from the annual accounts.
- Inventory days
- 0.00 days
- FY ending Mar 2026
How it is calculated
Reported inventory days, using material cost / cost of goods sold.
- Days payable
- —
- FY ending Mar 2026
How it is calculated
Reported payable days, using material cost / cost of goods sold.
- Cash conversion cycle
- 172.44 days
- FY ending Mar 2026
How it is calculated
Reported debtor days plus inventory days less payable days.
- Working capital days
- -359.25 days
- FY ending Mar 2026
How it is calculated
Reported net working capital days from the annual accounts.
- Dividend payout
- 0.00%
- FY ending Mar 2026
How it is calculated
Reported dividend payout as a percentage of annual profit.
- Market cap
- ₹24.70 Cr
- Current market cap
How it is calculated
Market capitalisation from the current stock record.
A dash means inputs are missing or too old, the ratio does not apply, or the value is outside our supported range. FY uses the reported fiscal period; TTM uses the latest twelve months. Valuations use current market cap with the selected earnings period.
Screen Indian stocks using these ratios →Financials, as filed
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Operating profit | ₹-0 Cr | ₹-0 Cr | ₹-0 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit | ₹-0 Cr | ₹-0 Cr | ₹-0 Cr |
| Cash from operations | ₹-0 Cr | ₹-0 Cr | ₹-1 Cr |
| Free cash flow | ₹-0 Cr | ₹-0 Cr | ₹-1 Cr |
How to read this
Reported financial amounts. Ratios and their reporting periods are shown above.
Balance sheet
| Year ending | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Reserves | ₹-3 Cr | ₹-3 Cr | ₹-3 Cr | ₹-3 Cr | ₹-4 Cr | ₹-4 Cr |
| Borrowings | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Other liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Total liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Fixed assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹-0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Total assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Aug 2026
Since Sep 2025, the public trimmed −35.72 pp while promoters added +35.70 pp. The shareholder count grew 1% to 2,457.
- Promoters
- 77.0%
- Public
- 23.0%
Since Sep 2025
- Public −35.72 pp
- Promoters +35.70 pp
How it drifted, 12 quarters
Over this window promoters went from 41.3% to 77.0% — +35.7 pp.
Ownership split by quarter, oldest first. Dec '23: Promoters 41.3%, Public 58.7%.Mar '24: Promoters 41.3%, Public 58.7%.Jun '24: Promoters 41.3%, Public 58.7%.Sep '24: Promoters 41.3%, Public 58.7%.Dec '24: Promoters 41.3%, Public 58.7%.Mar '25: Promoters 41.3%, Public 58.7%.Jun '25: Promoters 41.3%, Public 58.7%.Sep '25: Promoters 41.3%, Public 58.7%.Dec '25: Promoters 41.3%, Public 58.7%.Mar '26: Promoters 41.3%, Public 58.7%.Jun '26: Promoters 41.3%, Public 58.7%.Aug '26: Promoters 77.0%, Public 23.0%.
Who bought this quarter
since Jun 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Amit Mukesh Shah +13.42 pp 27.15% held
- Surbhit Mukesh Shah +11.93 pp 27.15% held
- Dhruvalkumar Patel newly disclosed 10.01% held
- Krima Surbhit Shah newly disclosed 3.00% held
- Ami Amit Shah newly disclosed 3.00% held
- Amitkumar Arunkumar Rao +2.84 pp 4.49% held
The same filing shows 3 holders trimming and 8 off the list — both are in the register beside this.
Who is on the register
Named in the Aug 2026 filing
Every holder of Rekvina Laboratories Ltd above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| Surbhit Mukesh Shah | 27.15% | +11.93 pp |
| Amit Mukesh Shah | 27.15% | +13.42 pp |
| Dhruvalkumar Patel | 10.01% | newly disclosed |
| Mukesh Jamnadas Shah | 6.69% | −5.65 pp |
| Amitkumar Arunkumar Rao | 4.49% | +2.84 pp |
| Krima Surbhit Shah | 3.00% | newly disclosed |
| Ami Amit Shah | 3.00% | newly disclosed |
| Arunkumar Narsingh Rao | 2.13% | −1.80 pp |
| Kishorbhai J Suratwala | 2.07% | −1.74 pp |
| Niravbhai Jashubhai Patel | — | off the list |
| Dilsan Pharma Impex Private Limited | — | off the list |
| Abhijit Dharmeshbhai Mehta | — | off the list |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Rekvina Laboratories Ltd
Guides on how to read this kind of business and the numbers that matter.